Agilent 2026-02-16 Agilent Technologies (A) Valuation Check After FDA Expansion Of Keytruda Companion Diagnostic - simplywall.st
Agilent 2026-02-16 Agilent Technologies (A) Stock Analysis: Unpacking A 34.86% Potential Upside For Investors - DirectorsTalk Interviews
Agilent 2026-02-15 Agilent Technologies Stock: Quiet Rally, Hard Questions – Is The Lab Giant Still A Buy After Its C - AD HOC NEWS
Agilent 2026-02-14 The Bull Case For Agilent Technologies (A) Could Change Following New PD-L1 Test Approval And Dividend News - simplywall.st
Agilent 2026-02-14 The Bull Case For Agilent Technologies (A) Could Change Following New PD-L1 Test Approval And Dividend News - Sahm
Agilent 2026-02-13 Agilent Technologies, Inc.'s (NYSE:A) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
Agilent 2026-02-13 FDA Ovarian Cancer Nod Puts Focus On Agilent Valuation And Momentum - simplywall.st
Agilent 2026-02-13 Agilent Technologies, Inc. (NYSE:A) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Agilent 2026-02-13 Agilent Receives FDA Approval for Companion Diagnostic in Ovarian Cancer - Femtech Insider
FierceBiotech 2026-02-12 Agilent companion diagnostic lands FDA nod alongside Keytruda's latest cancer approval
Agilent 2026-02-12 Agilent Technologies, Inc. (NYSE:A) to Issue $0.26 Quarterly Dividend - MarketBeat